Kairos Pharma, Ltd. (KAPA)

Kairos Pharma will go public soon, but the exact IPO date is still unknown.

IPO Price

$4.00

Shares Offered

1,550,000

Deal Size

$6.20M

Kairos Pharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021
Selling, General & Admin	0.48	1.76
Research & Development	0.09	0.18
Operating Expenses	0.57	1.94
Operating Income	-0.57	-1.94
Interest Expense / Income	0.05	0.02
Other Expense / Income	0.43	0.18
Pretax Income	-1.05	-2.15
Net Income	-1.05	-2.15
Free Cash Flow	-0.35	-0.41
EBITDA	-0.43	-1.88
Depreciation & Amortization	0.57	0.24
EBIT	-1	-2.13

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).